semaglutide shortage 2023 fda status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list GLP-1 No Longer on FDA's – Semaglutide Market Size, Share &

Obesity 32 , 232233 (2024)

Who Is Eligible Roughly 10% of Medicare enrollees (~3.4 million people) are expected to qualify for GLP-1 coverage

Store at room temperature 68 F77 F (20 C25 C)

Significant investments are being directed toward purification, lyophilization, and downstream processing capabilities, as these operations have become key bottlenecks in scaling commercial production of semaglutide and tirzepatide APIs

Final Thoughts: BPC 157 and TB 500 as Research Tools The growing interest in bpc 157 and tb 500 , bpc-157 and tb-500 , and related combinations reflects just how active the research landscape has become